Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA

被引:289
作者
Warnecke, PM
Stirzaker, C
Melki, JR
Millar, DS
Paul, CL
Clark, SJ
机构
[1] CSIRO,DIV MOL SCI,SYDNEY LAB,N RYDE,NSW 2113,AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP,KANEMATSU LABS,CAMPERDOWN,NSW 2050,AUSTRALIA
[3] UNIV SYDNEY,SCH BIOL SCI,SYDNEY,NSW 2006,AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.1093/nar/25.21.4422
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methylation analysis of individual cytosines in genomic DNA can be determined quantitatively by bisulphite treatment and PCR amplification of the target DNA sequence, followed by restriction enzyme digestion or sequencing. Methylated and unmethylated molecules, however, have different sequences after bisulphite conversion. For some sequences this can result in bias during the PCR amplification leading to an inaccurate estimate of methylation. PCR bias is sequence dependent and often strand-specific. This study presents a simple method for detection and measurement of PCR bias for any set of primers, and investigates parameters for overcoming PCR bias.
引用
收藏
页码:4422 / 4426
页数:5
相关论文
共 11 条
[1]  
Clark S. J., 1997, P151
[2]   CPNPG METHYLATION IN MAMMALIAN-CELLS [J].
CLARK, SJ ;
HARRISON, J ;
FROMMER, M .
NATURE GENETICS, 1995, 10 (01) :20-27
[3]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[4]  
CLARK SJ, 1995, DNA NUCLEOPROTEIN ST, P123
[5]   Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands [J].
Herman, JG ;
Graff, JR ;
Myohanen, S ;
Nelkin, BD ;
Baylin, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9821-9826
[6]  
Lawyer F C, 1993, PCR Methods Appl, V2, P275
[7]  
Lei H, 1996, DEVELOPMENT, V122, P3195
[8]   CPG ISLAND PROMOTER REGION METHYLATION PATTERNS OF THE INACTIVE-X-CHROMOSOME HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE (HPRT) GENE [J].
PARK, JG ;
CHAPMAN, VM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :7975-7983
[9]  
Paul CL, 1996, BIOTECHNIQUES, V21, P126
[10]  
Stirzaker C, 1997, CANCER RES, V57, P2229